A series of studies in the U.S. estimated that the average savings in direct healthcare costs from rotavirus and acute gastroenteritis were between $121 million and $231 million per year once rotavirus vaccines were introduced.
Full Citation:
Pindyck T, Tate JE, Parashar UD. 2018. A decade of experience with rotavirus vaccination in the United States – vaccine uptake, effectiveness, and impact. Expert Review of Vaccines. 17(7).
Title of Article: A decade of experience with rotavirus vaccination in the United States – vaccine uptake, effectiveness, and impact
Author(s): Pindyck T, Tate JE, Parashar UD
Publication Year: 2018
Publication Name: Expert Review of Vaccines
Publication Volume: 17(7)
Publication Source URL: https://www.ncbi.nlm.nih.gov/pubmed/29909693
DOI (Digital Object Identifier): 10.1080/14760584.2018.1489724
Topics: Economics & Return on Investment
Disease Vaccines: Rotavirus
Countries: United States
WHO Regions: Americans